A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease
Hong Ren, Wei Zhang, Xiaoping Luo, Jie Ma et al.
Journal
Orphanet Journal of Rare Diseases
Topics
Lysosomal Storage Disorders Research
article
A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease
Hong Ren, Wei Zhang, Xiaoping Luo, Jie Ma, Shi Liu, Yun Yuan, Bin Li, Junhong Guo, Nan Chen, Qiqi Feng, Qian Shen, Yan Ouyang, Xiaoxia Pan, Hong Xu
article en
Abstract
No abstract available for this paper.
Publication Tag
Orphanet Journal of Rare DiseasesVol. 20(1)
Institutions
Shanxi Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Peking Union Medical College Hospital (CN), Ruijin Hospital (CN), First Hospital of Shanxi Medical University (CN), Peking University First Hospital (CN), Sanofi (China) (CN), Children's Hospital of Fudan University (CN), Tongji Hospital (CN), Union Hospital (CN), Huazhong University of Science and Technology (CN)